Menu
Annual · values202520242023202220212020
Operating Cash Flow-4.24 M USD-8.26 M USD-5.81 M USD-5.82 M USD-10.67 M USD-288380 USD
Depreciation & Amortization1.73 M USD2.29 M USD2.12 M USD22433 USD45358 USD44758 USD
Stock-Based Compensation21266 USD249675 USD459666 USD678613 USD622064 USD92866 USD
Capital Expenditures454 USD31546 USD19478 USD215504 USD2550 USD426 USD
Cash Flow from Investing-1.00 M USD1.98 M USD-7.23 M USD-3.19 M USD-1.04 M USD-1.10 M USD
Cash Flow from Financing10.24 M USD5.82 M USD70889 USD-3.42 M USD38.75 M USD2.03 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-4.24 M USD-8.30 M USD-5.83 M USD-6.03 M USD-10.67 M USD-288806 USD

iSpecimen Inc. operates a proprietary online marketplace platform that connects life science researchers worldwide with hospitals, laboratories, and other organizations supplying human biospecimens, subjects, samples, and associated data. The iSpecimen Marketplace streamlines procurement by offering a diverse range of human biospecimens, including biofluids such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissues like fresh, fixed, cryopreserved samples, as well as formalin-fixed paraffin-embedded blocks, slides, and curls; and hematopoietic stem and immune cells from bone marrow, cord blood, whole blood, or isolated components like peripheral blood mononuclear cells. This platform addresses challenges in accessing high-quality, diverse specimens for research in diagnostics and therapeutics. iSpecimen Inc. serves biopharmaceutical companies, in vitro diagnostic firms, and government/academic institutions, facilitating faster biomedical discovery through efficient, compliant global networking. Founded in 2009 and headquartered in Woburn, Massachusetts, it plays a key role in the healthcare sector's diagnostics and research industry.